相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? A Systematic Review
Aaron P. Mitchell et al.
ANNALS OF INTERNAL MEDICINE (2021)
Industry self-regulation fails to deliver healthier diets, again Public Health England's replacement must take bolder action
Paraskevi Seferidi et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough
Joel Lexchin et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2021)
Pharmaceutical industry self-regulation and non-transparency: country and company level analysis of payments to healthcare professionals in seven European countries
Shai Mulinari et al.
HEALTH POLICY (2021)
Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational study
Frank Moriarty et al.
HEALTH POLICY (2021)
Enforcement of the Physician Payments Sunshine Act Trust and Verify
Eli Y. Adashi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Evaluation of Financial Conflicts of Interest Among Physician-Authors of American College of Rheumatology Clinical Practice Guidelines
Cole Wayant et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Overview and transparency of non-research payments to healthcare organizations and healthcare professionals from pharmaceutical companies in Japan: Analysis of payment data in 2016
Akihiko Ozaki et al.
HEALTH POLICY (2020)
Do Speakers Fully Disclose Potential Conflicts of Interest in Oral and Maxillofacial Surgery?
Idrys Durrani et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2020)
Financial ties between leaders of influential US professional medical associations and industry: cross sectional study
Ray Moynihan et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Declarations of pharma funding to doctors are hit by covid-19 crisis
Lynn Eaton
BMJ-BRITISH MEDICAL JOURNAL (2020)
Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016)
Piotr Ozieranski et al.
BMJ OPEN (2020)
Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016
Marlene Stoll et al.
BMJ OPEN (2020)
Assessing concordance of financial conflicts of interest disclosures with payments' databases: a systematic survey of the health literature
Hebah El-Rayess et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study
Lisa Parker et al.
BMJ OPEN (2019)
INVESTIGATION NHS joint working with industry is out of public sight
Tom Moberly
BMJ-BRITISH MEDICAL JOURNAL (2019)
Exposing drug industry funding of UK patient organisations
Piotr Ozieranski et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence
Ash Bullement et al.
PHARMACOECONOMICS (2019)
Shedding light on the HTA consultancy market: Insights from Poland
Marcell Csanadi et al.
HEALTH POLICY (2019)
Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK
Emily Rickard et al.
HEALTH POLICY (2019)
Open data on industry payments to healthcare providers reveal potential hidden costs to the public
Jorge Mejia et al.
NATURE COMMUNICATIONS (2019)
Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases
Bruno Goupil et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
The Sunshine Act and Surgeons: A Nation-Wide Analysis of Industry Payments to Physicians
Meghan E. Garstka et al.
JOURNAL OF SURGICAL RESEARCH (2019)
Pharmaceutical payments to physicians may increase prescribing for opioids
Thuy D. Nguyen et al.
ADDICTION (2019)
Transparency in practice: Evidence from 'verification analyses' issued by the Polish Agency for Health Technology Assessment in 2012-2015
Piotr Ozieranski et al.
HEALTH ECONOMICS POLICY AND LAW (2019)
Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015
Piotr Ozieranski et al.
JAMA NETWORK OPEN (2019)
Decoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia
Quinn Grundy et al.
HEALTH POLICY (2018)
EXCLUSIVE CCGs fail to declare pharma funding
Tom Moberly
BMJ-BRITISH MEDICAL JOURNAL (2018)
EXCLUSIVE CCGs fail to declare pharma funding
Tom Moberly
BMJ-BRITISH MEDICAL JOURNAL (2018)
Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry's Disclosure UK database, 2015 and 2016 cohorts
Shai Mulinari et al.
BMJ OPEN (2018)
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
Alice Fabbri et al.
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT (2018)
Industry self-regulation of alcohol marketing: a systematic review of content and exposure research
Jonathan K. Noel et al.
ADDICTION (2017)
US drug marketing: how does promotion correspond with health value?
Tyler Greenway et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
US drug marketing: how does promotion correspond with health value?
Tyler Greenway et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Industry sponsorship and research outcome
Andreas Lundh et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Disclosure UK: transparency should no longer be an optional extra
Kate Adlington et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study
William Fleischman et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Disclosure UK: transparency should no longer be an optional extra
Kate Adlington et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study
William Fleischman et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts
James S. Yeh et al.
JAMA INTERNAL MEDICINE (2016)
Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries
Colette DeJong et al.
JAMA INTERNAL MEDICINE (2016)
Complaints, Complainants, and Rulings Regarding Drug Promotion in the United Kingdom and Sweden 2004-2012: A Quantitative and Qualitative Study of Pharmaceutical Industry Self-Regulation
Anna V. Zetterqvist et al.
PLOS MEDICINE (2015)
分享论文
